Find answers to the most common questions you have regarding Parkinson's disease and DBS.

Expand All

Where can I find more information on DBS?

Where can I find more information on DBS?

Our education programme Support Link™ provides the support and resources you need to make an informed decision about DBS.

Click here to learn more

Does DBS prevent a person from using future treatments or cures?

Is DBS just for tremor (shaking)?

Is DBS a last resort treatment for Parkinson’s?

How effective is DBS therapy?

How long will the DBS therapy take to work after the implant procedure?

Will I feel the stimulation?

Can people resume their normal daily activities?

Will the neurostimulator be visible?

Will I be able to increase or decrease the strength of stimulation?

Is DBS therapy permanent?

Could DBS therapy cause damage to brain tissue?

Is it safe to have medical tests with a DBS system implanted?

Can I go through airport scanning with my implanted DBS neurostimulator?

Will I be able to have an MRI scan with a DBS system?

Can stimulation be used during pregnancy?



Medtronic Supplemental Analysis, Supplement to EPDA website update re patient barriers and claims-v17-Sept-2015

The “gold standard” of evaluating the success rate of DBS is based on the overall motor function evaluation using the UPDRS III scale. The scientifically accepted method for evaluation of the MCIC (minimally clinically important change) is at least 5 points in the UPDRS III scale. The evaluation of “off medication” allows reflection of the impact of DBS, albeit an artificially created OFF condition. It has not been typically reported in the publications, but we have done the above additional analyses of the databases available in both the published evidence (only randomised control trials have been considered for this). The above analysis works for Medtronic devices only.


Scelzo E, Mehrkens JH, Bötzel K, Krack P, Mendes A et al. Deep brain stimulation during pregnancy and delivery: experience from a series of “DBS babies”. Front Neurol. 2015 Sep 1;6:191.